Low - Dose ATLG Prevents GVHD in
Pediatric Hematologic Malignancies: A newly published randomized phase III study of
pediatric patients showed lower doses of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children with hematologic malignancies undergoing allogeneic
hematopoietic stem cell transplantation from an unrelated donor.